Accelr8 Technology Corporation Presents Two Studies at American Society for Microbiology 2012 and Receives Acceptance to Present a New Blood Study

June 22, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE MKT: AXK) announced results of two studies that it presented at the 112th annual General Meeting of the American Society for Microbiology (www.asm.org).

Twitter
LinkedIn
Facebook
Email
Print

Events